Immuneel Therapeutics Raises ₹100 Cr To Take Its Gene Therapy For Blood Cancer Global

by · Inc42

SUMMARY

  • Bengaluru-based Immuneel Therapeutics has raised ₹100 Cr Series B fundraise from Singularity AMC, Rainmatter by Zerodha
  • The round also saw participation from existing investors, including founder Kiran Mazumdar-Shaw, Eight Roads Ventures, F-Prime Capital, and several undisclosed HNIs
  • The fresh capital will be used to scale manufacturing, advance its therapy pipeline, and expand across Asia-Pacific and the Middle East